MEKTOVI® (binimetinib) | Pfizer Medical Information - US
MEKTOVI is indicated, in combination with encorafenib, for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) with a BRAF V600E mutation, as detected by an FDA-approved test. [see Dosage and Administration (2.1)]. MEKTOVI® Dosage and Administration (binimetinib) Dosage and Administration. 2 DOSAGE AND ADMINISTRATION.
Mektovi: Uses, Dosage, Side Effects, Warnings - Drugs.com
Mar 26, 2024 · Mektovi (binimetinib) is an oral kinase inhibitor that may be used in combination with encorafenib for the treatment of adults with unresectable or metastatic melanoma or metastatic non-small cell lung cancer (NSCLC) with a confirmed BRAF mutation.
Binimetinib - Wikipedia
Binimetinib, sold under the brand name Mektovi, is an anti-cancer medication used to treat various cancers. [4] Binimetinib is a selective inhibitor of MEK, a central kinase in the tumor-promoting MAPK pathway. [5] Inappropriate activation of the pathway has been shown to occur in many cancers. [5]
Home | BRAFTOVI® (encorafenib) + MEKTOVI® (binimetinib ...
See risks & benefits of BRAFTOVI® + MEKTOVI®, a combination treatment for adults with unresectable or metastatic melanoma with a BRAF V600E/K mutation. This site is intended for U.S. healthcare professionals.
MEKTOVI® | Pfizer
MEKTOVI U.S. Physician Prescribing Information. MEKTOVI - U.S. Medical Information Page - clinical & safety information, ways to contact Pfizer Medical & other resources. www.braftovimektovi.com.
MEKTOVI® Highlights - Pfizer Medical Information
DOSAGE AND ADMINISTRATION. Melanoma. •. Confirm the presence of BRAF V600E or V600K mutation in tumor specimens prior to the initiation of MEKTOVI. (2.1) •. The recommended dose is 45 mg orally twice daily in combination with encorafenib. Take MEKTOVI with or …
Mektovi: Uses, dosage, side effects, interactions, and more
Mar 6, 2024 · Mektovi is a brand-name oral tablet that’s prescribed for certain types of cancer. Mektovi contains the active ingredient binimetinib. Mektovi is FDA approved to treat the following types of...
- Some results have been removed